Ann: Fenix Board Appointment, page-169

First 169 Last

Share
Profile

Follow
CatsnDogs

1,488 Posts.

74

04/01/22

23:40

Post #: 58643232
Share

Originally posted by rookstar: ↑

100% agree with this post.

The agm wreaks of an ambush by people (sh) in the know or people calling the shots behind the scenes.
Imagine getting a call if you were the M/D, the day before the agm from a group sh's, the day before agm and being told whats happening at the meeting the following day.
2 directors resign that had both bought shares in the company, a new chairman which purchased shares in the company 1.5 mill worth, announced before the meeting held, only to take office after the agm was concluded, so no votes cast.
Then being issued with a share loan plan to be voted on in an egm to bolster his position.
Signs point to me that robs version is a formality rather than an endorsement. And now that welborn has the chair position, lets just hope that no shareholders gift the votes to the chair to cast independantly!.

Rob for my mind is scrambling for votes to save himself after the last agm results.
The proof is there in the agm.

We will soon find out who is actually running the company depending on the next play and where it goes to next.

For my mind FEX was about related materials to the off take partner like maganese and coal (sinosteel) and strengthening that business relationship. High quality product = niche producer!
There was a hint that we could utilize the neighbouring sinosteel tenement too. (Stranded assets)

Or we can recieve what wildcard welborn has on offer that we dont know about his plans, to then vote to give him not only a generous share price entry of $0.23, $2.3mill worth loan interest free shares which he owns straight up that comes with 100% voting rights straight off the bat, before we know his plan.
Total here if approved is 11.5 mill shares for john personally and he can use these vote next meeting.

The alternative assumption is they both get along (not likely) and they are both dressing FEX up to sell out when then share price goes on a massive surge.

Time will tell and vote accordingly.

Any one else feel free to add to the above.

Rooks

Expand

some interesting points raised Rooks

FEX Price at posting: 28.5¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

IRE

Iress runs 'hot' for Wealth Within's stock tips

Failure to report prompts ASX to impose multiple company suspensions

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 52 more messages in this thread...

First 169 Last

Add FEX (ASX) to my watchlist

(20min delay)
Last 28.0¢		Change -0.015(5.08%)		Mkt cap ! $201.7M

Open	High	Low	Value	Volume
29.0¢	29.0¢	28.0¢	$504.6K	1.767M

Buyers (Bids)

No.	Vol.	Price($)
10	329727	27.5¢

Sellers (Offers)

Price($)	Vol.	No.
28.0¢	17490	1

View Market Depth

No.	Vol.	Price($)
10	329727	0.275
5	62137	0.270
3	415107	0.265
3	42578	0.260
5	122753	0.255

Price($)	Vol.	No.
0.280	17490	1
0.285	477069	2
0.290	202892	5
0.295	20000	1
0.300	291008	11

Last trade - 16.10pm 01/10/2024 (20 minute delay)

FEX (ASX) Chart

Ann: Fenix Board Appointment, page-169

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Iress runs 'hot' for Wealth Within's stock tips

Failure to report prompts ASX to impose multiple company suspensions

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Fenix Board Appointment, page-169

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Iress runs 'hot' for Wealth Within's stock tips

Failure to report prompts ASX to impose multiple company suspensions

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News